Mast cell activation syndrome (MCAS) affects more than 15% of the U.S. population but evades most practitioners’ radar. Just five years ago, it wasn’t even on my radar, despite already having 20 years of experience as a clinician at that time. The more I dug (similar to leaky gut and post-COVID syndrome), the more I found my patients were suffering from this disorder.
Amanda Gaitaud, LAc, Dipl. OM
Amanda Gaitaud received her Master's of Science from PCOM. She's currently completing the final requirement to receive her DAOM. As vice president of the AAAOM Amanda was involved with both the burden of debt survey and analysis.